$23.22
0.713.15%
At close: -
$23.99
0.773.32%
After Hours: Dec 17, 8:07 AM EDT
Comments
Loading...
Cidara Therapeutics (CDTX) Forecast
NewsEarningsCidara Therapeutics (CDTX) OptionsGuidanceDividendsAnalyst RatingsInsider TradesShort InterestCidara Therapeutics (NASDAQ:CDTX) Stock Quotes, Forecast and News Summary
Cidara Therapeutics Stock (NASDAQ: CDTX) stock price, news, charts, stock research, profile.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Cidara Therapeutics (CDTX) stock?
You can purchase shares of Cidara Therapeutics (NASDAQ:CDTX) through any online brokerage.
Who are Cidara Therapeutics (CDTX) competitors?
Other companies in Cidara Therapeutics’s space includes: Renovaro (NASDAQ:RENB), 4D Molecular Therapeutics (NASDAQ:FDMT), Precigen (NASDAQ:PGEN), Zentalis Pharma (NASDAQ:ZNTL) and Larimar Therapeutics (NASDAQ:LRMR).
What is the forecast, or price target, for Cidara Therapeutics (CDTX) stock?
Cidara Therapeutics has a consensus price target of $32.20.
What is the current price for Cidara Therapeutics (CDTX)?
The stock price for Cidara Therapeutics (NASDAQ: CDTX) is $23.99 last updated December 17, 2024 at 8:07 AM EST.
Does Cidara Therapeutics (CDTX) pay a dividend?
There are no upcoming dividends for Cidara Therapeutics.
When is Cidara Therapeutics (NASDAQ:CDTX) reporting earnings?
Cidara Therapeutics’s Q3 earnings are confirmed for Thursday, November 7, 2024.
Is Cidara Therapeutics (CDTX) going to split?
There is no upcoming split for Cidara Therapeutics.
What sector and industry does Cidara Therapeutics (CDTX) operate in?
Cidara Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.